Chullin 47

Hook

Founders love to talk about "product-market fit" as if it’s a binary state—either you have it, or you don’t. But in the early stages, you’re constantly dealing with signals that look like product-market fit but are actually just noise or, worse, symptoms of a structural defect.

Think of the "two cysts" described in Chullin 47a: two bumps on the lung that look identical. One configuration is a fatal tereifa (a defect rendering the animal non-kosher), while the other is a harmless anomaly. The difference isn't in how they look—it’s in how they interact under pressure. When the Sages suggest using a thorn to pierce the cyst to see if the fluids flow together, they are teaching a brutal lesson in due diligence.

In your startup, you are constantly presented with "cysts"—growth metrics, user feedback, or revenue spikes. Are these signs of a healthy, cohesive system, or are they separate, conflicting signals covering up a fundamental perforation in your business model? If you don't stress-test the connection—if you don't "pierce" the data to see if it’s truly unified—you might be scaling a tereifa. Today, on Rosh Chodesh Tamuz, we reflect on the transition of the month. Just as the moon shifts from hidden to visible, your job as a founder is to force hidden structural defects into the light before they kill your burn rate.

Analysis

Insight 1: The Fallacy of Visual Consensus

Rava teaches that if you have two cysts adjacent to one another, they are a defect by default: Chullin 47a, "These two cysts that are adjacent to one another... have no need for inspection." He assumes that proximity implies a perforation.

In business, we often conflate correlation with systemic health. Just because two KPIs are moving in the same direction doesn’t mean they are driven by the same healthy engine. Founders often assume that if revenue is up and user engagement is up, the business is "kosher." But if those two metrics aren't linked by a single, sustainable value proposition, you are likely looking at two separate "cysts"—two different problems manifesting on the same surface. Do not assume that your growth metrics are inherently connected. If you cannot explain the mechanism that ties them together, assume the "lung" is perforated.

Insight 2: The Stress-Test as a Decision Rule

The Sages provide a brilliant, low-tech diagnostic: "We bring a thorn and pierce it... if the fluids from either side empty into one another, this indicates that it is one cyst, and the animal is kosher" Chullin 47a.

This is your MVP philosophy. When you see a positive signal, don't just admire the appearance; pierce it. Does your revenue flow directly from the user engagement you’re measuring? Or is the revenue coming from a legacy contract while the engagement is coming from a non-monetizable feature? If the "fluids" (the underlying causal logic) don't flow between your metrics, you have two separate, unrelated behaviors. A truly healthy system is a single, integrated vessel. If you can't trace the path from the "piercing" (the experiment) to the outcome (the fluid exchange), your business model is essentially a collection of unrelated parts masquerading as a cohesive strategy.

Insight 3: The Danger of "Little Rose Lobes" (Contextual Nuance)

Not every deviation is a death sentence. When Rav Ashi considered declaring an animal a tereifa due to an extra lobe, Rav Huna Mar bar Avya corrected him: "All those animals that graze outside in the fields have extra lobes like this, and butchers call it the little rose lobe" Chullin 47a.

This is the ultimate lesson in domain expertise. A founder who lacks industry context will flag every "extra lobe" as a fatal bug. A veteran operator knows the difference between an existential threat and a "little rose lobe"—a standard, healthy adaptation for the environment. Before you pivot or kill a project because it doesn't fit your "textbook" model, ask: Is this a structural perforation, or is this just how the market "grazes"? Don't kill your company by misinterpreting a standard industry feature as a systemic defect.

Policy Move

The "Fluidity Test" Protocol Every quarter, require your leadership team to perform a "Fluidity Audit" on your top three growth metrics.

1. The Piercing: Define one specific variable (e.g., a change in pricing, a UI update, or a marketing channel shift).
2. The Flow: Measure the ripple effect. If you pull this lever, does the secondary metric move in a predictable, unified way?
3. The Verdict: If the data shows that the metrics are reacting independently or inconsistently, you are managing "two cysts." You must either unify them through a refined strategy or cut the dead weight.

KPI Proxy: "Correlation-to-Causation Ratio." If your metrics are highly correlated but have no documented causal link via your internal "fluidity" testing, your business is at risk of being a tereifa. Aim for a 0.8+ R-squared value on your core unit economic drivers.

Board-Level Question

"We are currently seeing [Metric X] and [Metric Y] performing well. If we were to 'pierce' our current growth strategy by removing the primary driver of [Metric X], would [Metric Y] collapse, or does it have its own independent, sustainable life-support? If it is independent, are we managing one business or two disconnected experiments, and which one is actually a tereifa?"

Takeaway

The Sages of Chullin 47a aren't butchers; they are systems thinkers. They knew that the difference between life and death is often hidden just beneath the surface, protected by a membrane. As a founder, your job is to find the "thorns"—the rigorous experiments—that force the truth of your business out into the open. Don't let your business be defined by how it looks. Let it be defined by how it flows. On this Rosh Chodesh, remember: the new moon is a start, but only if you have the courage to inspect what lies behind the surface.